Sameer Agnihotri
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Mitochondrial Function and Pathology 9
- ATP Synthase and ATPases Research 7
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- Genetics 40
- Glioma Diagnosis and Treatment 39
- Co-authors
- Gelareh Zadeh (27 shared papers)Amparo Wolf (8 shared papers)Abhijit Guha (12 shared papers)Cynthia Hawkins (13 shared papers)N. Sabha (7 shared papers)Rob A. Cairns (3 shared papers)Joydeep Mukherjee (2 shared papers)Johann Micallef (2 shared papers)
- Journals
- Neuro-Oncology (10 papers)Oncotarget (5 papers)Nature Communications (4 papers)Neuro-Oncology Advances (3 papers)Molecular Oncology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Sameer Agnihotri
72 papers receiving 3.3k citations
Sameer Agnihotri's Hit Papers
Peers
Comparison fields: 5 of 118
- Genetics 933
- Cancer Research 1.2k
- Molecular Biology 1.8k
- Neurology 234
- Oncology 393
Countries citing papers authored by Sameer Agnihotri
This map shows the geographic impact of Sameer Agnihotri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Agnihotri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Agnihotri more than expected).
Fields of papers citing papers by Sameer Agnihotri
This network shows the impact of papers produced by Sameer Agnihotri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Agnihotri. The network helps show where Sameer Agnihotri may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Agnihotri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme Hit paper breakdown → | 2011 | 629 |
| 2 | 2015 | 229 | |
| 3 | 2019 | 204 | |
| 4 | 2012 | 187 | |
| 5 | 2010 | 153 | |
| 6 | 2011 | 139 | |
| 7 | 2019 | 135 | |
| 8 | 2014 | 118 | |
| 9 | 2016 | 110 | |
| 10 | 2017 | 107 | |
| 11 | 2011 | 94 | |
| 12 | 2022 | 72 | |
| 13 | 2011 | 65 | |
| 14 | 2014 | 62 | |
| 15 | 2019 | 58 | |
| 16 | 2018 | 57 | |
| 17 | 2022 | 57 | |
| 18 | 2016 | 57 | |
| 19 | 2017 | 53 | |
| 20 | 2015 | 49 |
About Sameer Agnihotri
Sameer Agnihotri is a scholar working on Molecular Biology, Genetics, Cancer Research, Cell Biology and Neurology, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (39 papers), Cancer, Hypoxia, and Metabolism (20 papers), Mitochondrial Function and Pathology (9 papers), Microtubule and mitosis dynamics (8 papers), ATP Synthase and ATPases Research (7 papers), Epigenetics and DNA Methylation (6 papers), Neuroblastoma Research and Treatments (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Genetics (933 citations), Cancer Research (1.2k citations), Molecular Biology (1.8k citations), Neurology (234 citations) and Oncology (393 citations). Sameer Agnihotri has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Gelareh Zadeh, Amparo Wolf, Abhijit Guha, Cynthia Hawkins, N. Sabha, Rob A. Cairns, Joydeep Mukherjee, Johann Micallef, Ian F. Pollack and Alberto Broniscer. Their work appears in journals such as Neuro-Oncology, Oncotarget, Nature Communications, Neuro-Oncology Advances and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.